136 related articles for article (PubMed ID: 6965945)
61. Local immune response in basal cell carcinoma: characterization by transmission electron microscopy and monoclonal anti-T6 antibody.
Murphy GF; Krusinski PA; Myzak LA; Ershler WB
J Am Acad Dermatol; 1983 Apr; 8(4):477-85. PubMed ID: 6602155
[TBL] [Abstract][Full Text] [Related]
62. Characterization of mononuclear cells in the inflammatory infiltrates of cutaneous tumours.
Viac J; Bustamante R; Thivolet J
Br J Dermatol; 1977 Jul; 97(1):1-10. PubMed ID: 329852
[TBL] [Abstract][Full Text] [Related]
63. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.
Andersson K; Waterboer T; Kirnbauer R; Slupetzky K; Iftner T; de Villiers EM; Forslund O; Pawlita M; Dillner J
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):189-95. PubMed ID: 18199724
[TBL] [Abstract][Full Text] [Related]
64. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy.
Stefano S; Kerman R; Abbate J
AJR Am J Roentgenol; 1976 Apr; 126(4):880-6. PubMed ID: 179361
[TBL] [Abstract][Full Text] [Related]
65. Th17 cytokines in non-melanoma skin cancer.
McAllister F; Kolls JK
Eur J Immunol; 2015 Mar; 45(3):692-4. PubMed ID: 25655439
[TBL] [Abstract][Full Text] [Related]
66. CD103 negative memory T cells may play important roles in making regulatory T-cell-enriched environments in skin tumours.
Nakamura Y; Watanabe R; Zhenjie Z; Koguchi-Yoshioka H; Vo S; Oya K; Matsumura Y; Tanaka R; Okiyama N; Ishitsuka Y; Fujimoto M; Fujisawa Y
J Eur Acad Dermatol Venereol; 2019 May; 33(5):e211-e214. PubMed ID: 30719755
[No Abstract] [Full Text] [Related]
67. Expression of the antigen recognized by mAb GB36 in normal skin and in skin tumours.
Hofman P; Lacour JP; Emiliozzi C; Staquet MJ; Hsi BL; Rossi B; Ortonne JP
Br J Dermatol; 1995 Dec; 133(6):874-83. PubMed ID: 8547038
[TBL] [Abstract][Full Text] [Related]
68. [Cellular reaction to tumor-tissue specimens from the orofacial region].
Jansa P; Podstata J
Cesk Stomatol; 1977 Jun; 77(3):179-83. PubMed ID: 268235
[No Abstract] [Full Text] [Related]
69. Cellular immune deficiency in black patients with basal cell carcinoma.
Burns JE; Eisenhauer ED; Jabaley ME; Cruse JM
J Surg Oncol; 1980; 13(2):129-34. PubMed ID: 6965744
[TBL] [Abstract][Full Text] [Related]
70. Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology.
Catalona WJ; Chretien PB
Cancer; 1973 Feb; 31(2):353-6. PubMed ID: 4687881
[No Abstract] [Full Text] [Related]
71. Cell-mediated immunity of patients who have had basal cell carcinomas.
Czarnecki D; Mar A; Kulinskaya E
Acta Derm Venereol; 1996 Jan; 76(1):28-30. PubMed ID: 8721486
[TBL] [Abstract][Full Text] [Related]
72. The relative effects of different systemic immunosuppressives on skin cancer development in organ transplant patients.
Durando B; Reichel J
Dermatol Ther; 2005; 18(1):1-11. PubMed ID: 15842607
[TBL] [Abstract][Full Text] [Related]
73. Altered bacterial flora and clinical course with intraoral cancer.
Rice DH; Weimert TA
Laryngoscope; 1978 Nov; 88(11):1861-3. PubMed ID: 713677
[TBL] [Abstract][Full Text] [Related]
74. [Activity of B- and T-lymphocytes in selected skin diseases determined by the rosette formation and blast transformation tests].
Mosakowska-Glińska M
Ann Acad Med Stetin; 1979; 25():387-404. PubMed ID: 395866
[No Abstract] [Full Text] [Related]
75. Lymphocyte subpopulation in primary lung cancer.
Alsabti EA; Safo MH; Shaheen A
Oncology; 1979; 36(4):176-9. PubMed ID: 224357
[TBL] [Abstract][Full Text] [Related]
76. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
Dumas V; Kanitakis J; Charvat S; Euvrard S; Faure M; Claudy A
Anticancer Res; 1999; 19(4B):2929-38. PubMed ID: 10652575
[TBL] [Abstract][Full Text] [Related]
77. Antigenic alterations in tumors of epidermal origin.
Tosca A; Varelzidis A; Nicolis G; Hadzis J; Stratigos J; Capetanakis J
Cancer; 1980 May; 45(9):2284-90. PubMed ID: 7379027
[TBL] [Abstract][Full Text] [Related]
78. Examining the association of non-melanoma skin cancer with immunomodulatory conditions: a cross-sectional analysis of the All of Us database.
Jean-Pierre P; Nouri K
Arch Dermatol Res; 2024 May; 316(5):161. PubMed ID: 38734810
[No Abstract] [Full Text] [Related]
79. Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia.
Rashid K; Ng R; Mastan A; Sager D; Hirschman R
Leuk Lymphoma; 2005 Jul; 46(7):1051-5. PubMed ID: 16019557
[TBL] [Abstract][Full Text] [Related]
80. Immunologic evaluation and prognosis in patients with head and neck cancer.
Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
